Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | KCNJ6 | P48051 | 1/20 | 0.41 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.41 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23082190 | 0.83 | RAB9A (0.49) | RAB9ANPC1SMN1; SMN2HPGDTSHR | |
| SCHEMBL23082179 | 0.76 | MAPT (0.47) | RAB9ANPC1SMN1; SMN2MAPTLMNA | |
| SCHEMBL24890427 | 0.75 | NPC1 (0.41) | RAB9ANPC1SMN1; SMN2HPGDMAPT | |
| SCHEMBL25091647 | 0.74 | NPC1 (0.41) | RAB9ANPC1SMN1; SMN2TSHRMAPT | |
| SCHEMBL19332135 | 0.73 | RAB9A (0.50) | RAB9ANPC1SMN1; SMN2HPGDTSHR | |
| SCHEMBL21699888 | 0.71 | RAB9A (0.48) | RAB9ANPC1SMN1; SMN2HPGDTSHR | |
| SCHEMBL24348224 | 0.71 | ALDH1A1 (0.31) | LMNAALDH1A1 | |
| SCHEMBL24890412 | 0.71 | LPO (0.31) | — | |
| SCHEMBL24348223 | 0.71 | MEN1 (0.34) | RAB9ANPC1HPGDTSHRLMNA | |
| SCHEMBL24890524 | 0.71 | RAB9A (0.55) | RAB9ANPC1SMN1; SMN2HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230012560-A1 | HEPATITIS B ANTIVIRAL AGENTS | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230012560-A1 | HEPATITIS B ANTIVIRAL AGENTS | SRR, SLC10A1, NR1H4 | RAB9A 357/4885NPC1 1259/4885SMN1; SMN2 3194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.